P

Inventor

FAUTI TANJA

CH10 patents
⚠️ This page may combine multiple inventors who share the name “FAUTI TANJA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ENGMAB AG

3 patents
US9963513B2May 8, 2018

Method for the selection of antibodies against BCMA

ENGMAB AG19 citations92
US10077315B2Sep 18, 2018

Bispecific antibodies against CD3 and BCMA

ENGMAB AG6 citations82
US10253104B2Apr 9, 2019

Bispecific antibodies against CD3ϵ and BCMA

ENGMAB AG10 citations81

HOFFMANN LA ROCHE

3 patents
US11608376B2Mar 21, 2023

Tumor-targeted agonistic CD28 antigen binding molecules

HOFFMANN LA ROCHE14 citations82
US10766967B2Sep 8, 2020

Bispecific T cell activating antigen binding molecules

HOFFMANN LA ROCHE1 citations62
US11987632B2May 21, 2024

Antibodies binding to HLA-A2/MAGE-A4

HOFFMANN LA ROCHE1 citations56

ROCHE GLYCART AG

2 patents
US10087250B2Oct 2, 2018

Fc-free antibodies comprising two fab-fragments and methods of use

ROCHE GLYCART AG10 citations83
US11639397B2May 2, 2023

Bispecific antibodies specific for T-cell activating antigens and a tumor antigen and methods of use

ROCHE GLYCART AG0 citations62

ENGMAB SARL

1 patent
US10851171B2Dec 1, 2020

Method for the selection of antibodies against BCMA

ENGMAB SARL1 citations71

BRISTOL MYERS SQUIBB CO

1 patent
US11952421B2Apr 9, 2024

Bispecific antibodies against CD3EPSILON and ROR1

BRISTOL MYERS SQUIBB CO0 citations60